您使用提示模式 关闭
为了方块之间的快速移动

组织机构: Warner Chilcott

机构名称
Warner Chilcott Plc
国家名称
爱尔兰
注册登记国
爱尔兰
行业
药品生产和生物技术
债券负债
-

探索最全面的数据库

80 万

债券

超过 400

定价来源

8 万

股票

9 千

ETF

以最有效的方式跟踪您的投资组合
债券筛选器
观察列表
Excel 附加组件

最新数据在

卖价

查询已发送
无法访问
信息提供者所提供的报价仅供参考。

简介

Warner Chilcott Public Limited Company is a specialty pharmaceutical company. It is focused on the women’s healthcare, gastroenterology, dermatology and urology segments of the branded pharmaceuticals market, primarily in North America. It is an integrated company with internal resources focused on the development, manufacture and promotion of its products. Its women’s healthcare franchise is anchored by its presence in the hormonal contraceptive, osteoporosis and hormone therapy (HT) markets. The Company’s hormonal contraceptive product offerings include LOESTRIN 24 FE (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets), the branded product in the United States hormonal contraception market, and LO LOESTRIN FE (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets), its new oral contraceptive product that offers women the lowest dosage of estrogen of any oral contraceptive.

奖项

相关文件

股票

最近一次的发行

债券负债 (按货币)

代码

  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001323854

信用和 ESG 评级

宏观经济指数

你必须 注册 才能获得访问权